Women bear disproportionate HIV burden as treatment gaps persist

HIV continues to disproportionately affect women in South Africa despite advancements in treatment and viral suppression. Out of the 7.8 million people living with the virus, more than half are women. National initiatives are making progress in treatment, but experts highlight critical gaps. This was discussed during a National Health Laboratory Service webinar focused on women's health challenges.

The Department of Health aimed to provide treatment to 1.67 million people in KwaZulu-Natal, but only 1.57 million received it. In Gauteng, the target of 1.49 million was met with only 1.29 million receiving treatment. NICD Centre for HIV and STIs head Dr Leigh Berrie reported that 7.8 million South Africans are living with HIV, with 5.1 million being women (15.7% prevalence).

New infections have risen by 12.3%, with over half being women (85,958), exacerbating the burden on women. South Africa aims to end the HIV epidemic by 2030 through the UNAIDS 2030 95-95-95 strategy, which targets 95% of people knowing their status, 95% on treatment, and 95% achieving viral suppression. Berrie noted that South Africa has 6.1 million people on antiretroviral treatment, with 4.2 million being women.

Progress has been made, but challenges remain, particularly among younger age groups, especially adolescent girls and young women, who are at high risk of HIV infection. Stigma, lack of awareness, and low uptake of prevention services contribute to the issue. For women living with HIV, the risk of HPV infection is six times higher, increasing the risk of cervical cancer.

Gaps in early detection, screening, and follow-up care for HPV among women living with HIV hinder efforts to provide timely and effective care.